재발한 악성 갈색세포종 환자에서 131I-Metaiodobenzylguanidine (131I-MIBG) 치료 후 131I-MIBG와 18F-FDG PET/CT 영상의 차이점 (A Discrepancy between 131I-Metaiodobenzylguanidine (131I-MIBG) Scintigraphy and 18F-FDG PET/CT after 131I-MIBG Therapy in a Patient with Recurred Malignant Pheochromocytoma) |
Author |
김근호, 김성민, 서영덕, |
Kun-Ho Kim, M.D., Seong-Min Kim, M.D., Ph.D., and Young-Duk Seo, M.D. |
Affiliation |
충남대학병원 핵의학과 Department of Nuclear Medicine, Chungnam National University Hospital, Daejeon, Korea. |
Abstract |
A 59-year-old woman who was diagnosed with malignant pheochromocytoma underwent 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT). She had undergone left adrenalectomy for pheochromocytoma 4 years previously. Recent multiple metastatic pulmonary nodules were noted on the chest X-ray. After treatment with 131I-metaiodobenzylguanidine (131I-MIBG) with 7.4 GBq, post-therapy 131I-MIBG scintigraphy depicted multiple distant metastases including lung, liver, abdominal para-aortic and mesenteric lymph nodes. 18F-FDG PET/CT also depicted multiple metastases in lung, liver, and abdominal para-aortic lymph nodes, but some lesions were not shown. In this case, 131I-MIBG scintigraphy found additional lesions in metastatic malignant pheochromocytoma. |
Keyword |
Malignant pheochromocytoma, 131I-metaiodobenzylguanidine (131I-MIBG), 18F-FDG PET/CT |
Full text Article |
4306582587.pdf
|
|
|